Literature DB >> 17785444

Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in Xenopus development.

Kiyotoshi Satoh1, Junji Ohnishi, Atsushi Sato, Michio Takeyama, Shun-ichiro Iemura, Tohru Natsume, Hiroshi Shibuya.   

Abstract

The development of anterior neural structure in Xenopus laevis requires the inhibition of bone morphogenic protein 4 and Wnt signaling. We previously reported that Nemo-like kinase (NLK) negatively regulates Wnt signaling via the phosphorylation of T-cell factor/lymphoid enhancer factor. However, the molecular events occurring downstream of NLK pathways in early neural development remain unclear. In the present study, we identified the transcription factor myocyte enhancer factor 2A (MEF2A) as a novel substrate for NLK. NLK regulates the function of Xenopus MEF2A (xMEF2A) via phosphorylation, and this modification can be inhibited by the depletion of endogenous NLK. In Xenopus embryos, the depletion of either NLK or MEF2A results in a severe defect in anterior development. The endogenous expression of anterior markers was blocked by the depletion of endogenous Xenopus NLK (xNLK) or xMEF2A but, notably, not by the depletion of other xMEF2 family proteins, xMEF2C and xMEF2D. Defects in head formation or the expression of the anterior marker genes caused by the depletion of endogenous xMEF2A could be eliminated by the expression of wild-type xMEF2A, but not xMEF2A containing mutated xNLK phosphorylation sites. Furthermore, the expression of xNLK-induced anterior markers was efficiently blocked by the depletion of endogenous xMEF2A in animal pole explants. These results show that NLK specifically regulates the MEF2A activity required for anterior formation in Xenopus development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785444      PMCID: PMC2169051          DOI: 10.1128/MCB.01481-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Specification of the vertebrate eye by a network of eye field transcription factors.

Authors:  Michael E Zuber; Gaia Gestri; Andrea S Viczian; Giuseppina Barsacchi; William A Harris
Journal:  Development       Date:  2003-08-27       Impact factor: 6.868

2.  Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A.

Authors:  David M Cox; Min Du; Michaela Marback; Eric C C Yang; Joseph Chan; K W Michael Siu; John C McDermott
Journal:  J Biol Chem       Date:  2003-02-12       Impact factor: 5.157

3.  Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction.

Authors:  Bisei Ohkawara; Kyoko Shirakabe; Junko Hyodo-Miura; Ritsuko Matsuo; Naoto Ueno; Kunihiro Matsumoto; Hiroshi Shibuya
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

Review 4.  Dorsal-ventral patterning and neural induction in Xenopus embryos.

Authors:  Edward M De Robertis; Hiroki Kuroda
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

5.  Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.

Authors:  Xiaoming Gong; Xiaoli Tang; Marcus Wiedmann; Xuemin Wang; Junmin Peng; Dong Zheng; Leslie A C Blair; John Marshall; Zixu Mao
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

6.  Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation.

Authors:  E Suzuki; K Guo; M Kolman; Y T Yu; K Walsh
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

7.  Activation of Xenopus MyoD transcription by members of the MEF2 protein family.

Authors:  M W Wong; M Pisegna; M F Lu; D Leibham; M Perry
Journal:  Dev Biol       Date:  1994-12       Impact factor: 3.582

Review 8.  Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival.

Authors:  Kim A Heidenreich; Daniel A Linseman
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

9.  Localization of specific mRNAs in Xenopus embryos by whole-mount in situ hybridization.

Authors:  A Hemmati-Brivanlou; D Frank; M E Bolce; B D Brown; H L Sive; R M Harland
Journal:  Development       Date:  1990-10       Impact factor: 6.868

10.  Muscle-specific expression of SRF-related genes in the early embryo of Xenopus laevis.

Authors:  A E Chambers; S Kotecha; N Towers; T J Mohun
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  12 in total

1.  Dual functions of DP1 promote biphasic Wnt-on and Wnt-off states during anteroposterior neural patterning.

Authors:  Wan-Tae Kim; Hyunjoon Kim; Vladimir L Katanaev; Seung Joon Lee; Tohru Ishitani; Boksik Cha; Jin-Kwan Han; Eek-Hoon Jho
Journal:  EMBO J       Date:  2012-07-06       Impact factor: 11.598

2.  NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells.

Authors:  Zhujun Tan; Maolan Li; Wenguang Wu; Lin Zhang; Qichen Ding; Xiangsong Wu; Jiasheng Mu; Yingbin Liu
Journal:  Mol Cell Biochem       Date:  2012-06-24       Impact factor: 3.396

3.  Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.

Authors:  Yasushi Ogawa; Yosuke Nonaka; Toshiyasu Goto; Eriko Ohnishi; Toshiyuki Hiramatsu; Isao Kii; Miyo Yoshida; Teikichi Ikura; Hiroshi Onogi; Hiroshi Shibuya; Takamitsu Hosoya; Nobutoshi Ito; Masatoshi Hagiwara
Journal:  Nat Commun       Date:  2010-10-05       Impact factor: 14.919

4.  Nemo-like kinase, an essential effector of anterior formation, functions downstream of p38 mitogen-activated protein kinase.

Authors:  Eriko Ohnishi; Toshiyasu Goto; Atsushi Sato; Mi-Sun Kim; Shun-Ichiro Iemura; Tohru Ishitani; Tohru Natsume; Junji Ohnishi; Hiroshi Shibuya
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

5.  Homodimerization of Nemo-like kinase is essential for activation and nuclear localization.

Authors:  Shizuka Ishitani; Kenji Inaba; Kunihiro Matsumoto; Tohru Ishitani
Journal:  Mol Biol Cell       Date:  2010-11-30       Impact factor: 4.138

6.  Selective inhibition of the kinase DYRK1A by targeting its folding process.

Authors:  Isao Kii; Yuto Sumida; Toshiyasu Goto; Rie Sonamoto; Yukiko Okuno; Suguru Yoshida; Tomoe Kato-Sumida; Yuka Koike; Minako Abe; Yosuke Nonaka; Teikichi Ikura; Nobutoshi Ito; Hiroshi Shibuya; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  Nat Commun       Date:  2016-04-22       Impact factor: 14.919

7.  Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart.

Authors:  Ruijie Liu; Hadi Khalil; Suh-Chin J Lin; Michelle A Sargent; Allen J York; Jeffery D Molkentin
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

8.  Transcriptional regulation of mesoderm genes by MEF2D during early Xenopus development.

Authors:  Alina Kolpakova; Sandra Katz; Aviad Keren; Adi Rojtblat; Eyal Bengal
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

9.  Association of nuclear-localized Nemo-like kinase with heat-shock protein 27 inhibits apoptosis in human breast cancer cells.

Authors:  Gina Shaw-Hallgren; Katarzyna Chmielarska Masoumi; Reihaneh Zarrizi; Ulf Hellman; Per Karlsson; Khalil Helou; Ramin Massoumi
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

10.  WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway.

Authors:  Toshiyasu Goto; Junhei Matsuzawa; Shun-Ichiro Iemura; Tohru Natsume; Hiroshi Shibuya
Journal:  FEBS Lett       Date:  2016-05-03       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.